Holen Sie sich die Stockscreener-App
20.88
12.62%
2.34
Handel nachbörslich:
20.63
-0.25
-1.20%
Schlusskurs vom Vortag:
$18.54
Offen:
$18.815
24-Stunden-Volumen:
4.72M
Relative Volume:
1.97
Marktkapitalisierung:
$2.11B
Einnahmen:
$352.57M
Nettoeinkommen (Verlust:
$-143.01M
KGV:
-11.54
EPS:
-1.81
Netto-Cashflow:
$-153.40M
1W Leistung:
+27.63%
1M Leistung:
+11.66%
6M Leistung:
-20.03%
1J Leistung:
-13.65%
1-Tages-Spanne:
$18.72
$20.92
1-Wochen-Bereich:
$16.02
$20.92
52-Wochen-Spanne:
$13.53
$35.25
Beam Therapeutics Inc Stock (BEAM) Company Profile
Firmenname
Beam Therapeutics Inc
Sektor
Branche
Telefon
857-327-8775
Adresse
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Vergleichen Sie BEAM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc
|
20.88 | 1.88B | 352.57M | -143.01M | -153.40M | -1.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-10 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-01-29 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-08 | Herabstufung | Jefferies | Buy → Hold |
| 2023-10-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-10-20 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-03-21 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-02-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-20 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-12-13 | Eingeleitet | Citigroup | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2022-04-28 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-05 | Eingeleitet | Guggenheim | Buy |
| 2021-10-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Fortgesetzt | Stifel | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-11 | Eingeleitet | Redburn | Buy |
| 2021-05-04 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-03-01 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-02-16 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-01-06 | Eingeleitet | Stifel | Hold |
| 2020-08-05 | Eingeleitet | William Blair | Outperform |
| 2020-03-02 | Eingeleitet | Barclays | Overweight |
| 2020-03-02 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-02 | Eingeleitet | Jefferies | Buy |
| 2020-03-02 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Beam Therapeutics Inc Aktie (BEAM) Neueste Nachrichten
Is Beam Therapeutics Inc. trading at a discountShort Setup & Free Weekly Chart Analysis and Trade Guides - 강소기업뉴스
Risk adjusted return profile for Beam Therapeutics Inc. analyzedPortfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser
Tick level data insight on Beam Therapeutics Inc. volatility2025 Trade Ideas & Reliable Intraday Trade Plans - Newser
Is Beam Therapeutics Inc. likely to announce a buybackM&A Rumor & Smart Allocation Stock Reports - خودرو بانک
Will Beam Therapeutics Inc. benefit from seasonality2025 Fundamental Recap & AI Forecasted Entry and Exit Points - خودرو بانک
Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences - FinancialContent
Can technical indicators confirm Beam Therapeutics Inc.’s reversalJuly 2025 Recap & AI Powered Market Trend Analysis - Newser
Beam Therapeutics Inc. stock trendline breakdownSwing Trade & Verified Chart Pattern Trade Signals - Newser
Can Beam Therapeutics Inc. recover in the next quarterEarnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Detecting price anomalies in Beam Therapeutics Inc. with AIPortfolio Profit Report & Breakout Confirmation Alerts - Newser
Is this a good reentry point in Beam Therapeutics Inc.July 2025 Trends & Real-Time Chart Breakout Alerts - Newser
Can trapped investors hope for a rebound in Beam Therapeutics Inc.July 2025 Chart Watch & Verified Momentum Watchlists - Newser
Understanding Beam Therapeutics Inc.’s price movementWeekly Earnings Recap & Accurate Intraday Trading Signals - Newser
Evaluating Beam Therapeutics Inc. with trendline analysisJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Beam Therapeutics shares fall 3.73% intraday after presenting at Citi's Biopharma Back. - AInvest
Will Beam Therapeutics Inc. rebound enough to break even2025 Top Decliners & Consistent Return Investment Signals - Newser
Analyzing Beam Therapeutics Inc. with multi timeframe charts2025 Price Momentum & Risk Controlled Stock Alerts - Newser
Combining price and volume data for Beam Therapeutics Inc.Market Performance Recap & Reliable Breakout Forecasts - Newser
Sentiment analysis tools applied to Beam Therapeutics Inc.Weekly Gains Summary & Verified Entry Point Signals - Newser
Beam Therapeutics’ Strategic Position in Base Editing and Pipeline Progress - AInvest
Chart based analysis of Beam Therapeutics Inc. trendsMarket Trend Review & Safe Capital Preservation Plans - Newser
Beam Therapeutics’ Unexpected Surge: Analyzing the Latest Performance - StocksToTrade
US Stocks Recap: Will Beam Therapeutics Inc. benefit from AI trendsMarket Trend Summary & Reliable Breakout Forecasts - خودرو بانک
Beam Therapeutics’ Stock Soars as Cathie Wood’s ARK Buys Shares - timothysykes.com
Beam Therapeutics Surges 13% on Intraday Rally – What’s Fueling the Momentum? - AInvest
Is this a good reentry point in Beam Therapeutics IncTrade Risk Report & AI Based Buy and Sell Signals - Newser
Applying Elliott Wave Theory to Beam Therapeutics Inc.July 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Intraday pattern recognizer results for Beam Therapeutics IncJuly 2025 Setups & AI Forecast Swing Trade Picks - Newser
Can trapped investors hope for a rebound in Beam Therapeutics IncWeekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
Intraday pattern recognizer results for Beam Therapeutics Inc.2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Is Beam Therapeutics Inc. forming a reversal patternJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Market reaction to Beam Therapeutics Inc.’s recent news2025 Buyback Activity & Reliable Momentum Entry Alerts - Newser
Beam Therapeutics Inc. stock outlook for YEARInsider Buying & High Conviction Investment Ideas - Newser
Applying Wyckoff theory to Beam Therapeutics Inc. stockTrend Reversal & High Accuracy Buy Signal Tips - Newser
Does Beam Therapeutics Inc. align with a passive investing strategy2025 Top Gainers & Risk Controlled Stock Alerts - خودرو بانک
What are Beam Therapeutics Inc.’s earnings expectationsJuly 2025 Reactions & Consistent Growth Equity Picks - khodrobank.com
How to manage a losing position in Beam Therapeutics Inc.2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
What high frequency data says about Beam Therapeutics Inc.2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Does Beam Therapeutics Inc. have a sustainable dividendJuly 2025 Market Mood & Breakout Confirmation Trade Signals - خودرو بانک
Will Beam Therapeutics Inc. benefit from geopolitical trendsJuly 2025 PreEarnings & High Return Stock Watch Alerts - خودرو بانک
Analyzing net buyer seller activity in Beam Therapeutics Inc.Trade Exit Summary & Detailed Earnings Play Alerts - Newser
What MACD and RSI say about Beam Therapeutics Inc.Weekly Volume Report & Expert Approved Momentum Trade Ideas - Newser
Is Beam Therapeutics Inc. stock bottoming outMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser
Finanzdaten der Beam Therapeutics Inc-Aktie (BEAM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):